hmg in Vietnamese

Viết tắt
Her/His Majesty's Government: chính phủ Hoàng gia.

Sentence patterns related to "hmg"

Below are sample sentences containing the word "hmg" from the English - Vietnamese Medical Dictionary. We can refer to these sentence patterns for sentences in case of finding sample sentences with the word "hmg", or refer to the context using the word "hmg" in the English - Vietnamese Medical Dictionary.

1. The degradation of HMG-CoA reductase is tightly controlled.

Sự giáng hóa của HMG-CoA reductase được kiểm soát chặt chẽ.

2. The repertoire of Adducted proteins is enriched for histones, HMG proteins, and proteins involved in RNA splicing

3. (99) Moreover, the abovementioned amount is only the minimum of supplies from Endemol to HMG which is guaranteed.

4. Simvastatin is a known inhibitor of HMG-CoA reductase, and most importantly is able to cross the blood–brain barrier.

Simvastatin là một chất ức chế được biết đến của HMG-CoA reductase, và quan trọng nhất là có thể vượt qua hàng rào máu não.

5. The absolute bioavailability of the medication is about 14%, but the systemic availability for HMG-CoA reductase activity is approximately 30%.

6. Given in high doses (> # IU/kg/day) follitropin alfa caused a decrease in the number of viable foetuses without being a teratogen, and dystocia similar to that observed with urinary hMG

7. When cholesterol levels fall, SREBP is released from the nuclear membrane or endoplasmic reticulum, it then migrates to the nucleus and causes the transcription of the HMG-CoA reductase gene.

Khi mức cholesterol giảm, SREBP được giải phóng từ màng nhân hoặc lưới nội chất, sau đó nó di chuyển đến nhân và gây ra phiên mã của gen reductase HMG-CoA.

8. /EXPTL THER/ The results of the present report show that alpha-Asarone was an inhibitor of hepatic HMG-CoA reductase and that the administration of alpha-Asarone at 80 mg/kg bw for 8 days decreased serum cholesterol by 38% (p < 0.001) in hypercholesterolemic rats.

9. More particularly, the present invention relates to a controlled-release drug delivery system for a combination of an angiotensin-II-receptor blocker and an HMG-CoA reductase inhibitor which releases the drugs at optimal rates for their in vivo absorption, maximizes effects and improves patient compliance.